Identification of ZG16B as a prognostic biomarker in breast cancer

Identification of ZG16B as a prognostic biomarker in breast cancer

Zymogen granule protein 16B (ZG16B) has been identified in various cancers, while so far the association between ZG16B and breast cancer hasn’t been explored. Our aim is to confirm whether it can serve as a prognostic biomarker in breast cancer. In this study, Oncomine, Cancer Cell Line Encyclopedia...

Full description

Bibliographic Details
Main Authors: Lu Haotian, Shi Chunying, Liu Xinyu, Liang Chen, Yang Chaochao, Wan Xueqi, Li Ling, Liu Ying
Format: Article
Language:English
Published: De Gruyter 2020-11-01
Series:Open Medicine
Subjects:
zg16b
breast cancer
database
biomarker
prognosis
Online Access:https://doi.org/10.1515/med-2021-0004

Internet

https://doi.org/10.1515/med-2021-0004

Similar Items